End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.21 CNY | +1.00% |
|
-0.37% | +41.50% |
05-13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
04-25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
- Stock Market
- Equities
- 600285 Stock
- Revisions Henan Lingrui Pharmaceutical Co., Ltd.